ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,870.62
-1.32%
US Tech 100
19,941.20
0.39%
Dow Jones
43,444.99
-0.70%
Brent Oil
71.345
0.91%
Bitcoin
90,452.47
0.65%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Obagi Medical Products, Inc. (MM) (OMPI) Quote

Obagi Medical Products, Inc. (MM)

Obagi Medical Products, Inc. (MM) (OMPI)

NASDAQ
23.98
0.00
(0.00%)
Closed November 15 4:00PM
Delayed by 15 minutes
23.98
0.00
( 0.00% )
Pre Market: 7:00PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
23.98
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
23.98
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

OMPI Latest News

More News

Crestwood to Acquire Oasis Midstream Partners in $1.8 Billion Transaction

Highly complementary Williston Basin and Delaware Basin assets enhance Crestwood’s competitive positioning in its core growth basins Significantly expands Crestwood’s leading position in the...

October 26 2021
Business Wire

Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.

Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc. PR Newswire LAVAL, Quebec, April 25, 2013 LAVAL, Quebec, April 25, 2013 /PRNewswire/ -- Valeant...

April 25 2013
PR Newswire (US)

Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its...

Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously Announced Acquisition of Obagi Medical Products, Inc. PR...

April 24 2013
PR Newswire (US)

Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstand...

Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc. PR...

April 23 2013
PR Newswire (US)

Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisitio...

Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc. PR Newswire MONTREAL, April 22, 2013...

April 22 2013
PR Newswire (US)

Valeant: The Sole Suitor for Obagi - Analyst Blog

Valeant Pharmaceuticals’ (VRX) proposed acquisition of Obagi Medical Products, Inc. (OMPI) received a boost with Merz Pharma Group opting out of the race to purchase Obagi. Merz’s...

April 09 2013
Zacks

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Among the companies with shares expected to actively trade in Monday's session are Lufkin Industries Inc. (LUFK), Obagi Medical Products Inc. (OMPI) and Constellation Brands Inc. (STZ). General...

April 08 2013
Dow Jones News

Merz Pharma Withdraws Offer for Obagi Medical After Valeant's Sweetened Bid

By Tess Stynes Merz Pharma Group withdrew its roughly $385 million offer to acquire Obagi Medical Products Inc. (OMPI), citing Valeant Pharmaceuticals International Inc.'s (VRX, VRX.T) sweetened...

April 08 2013
Dow Jones News

Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products

Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products PR Newswire FRANKFURT, Germany, April 8, 2013 FRANKFURT, Germany, April 8, 2013 /PRNewswire/ -- Merz Pharma Group...

April 08 2013
PR Newswire (US)

Valeant Ups Offer for Obagi - Analyst Blog

Valeant Pharmaceuticals (VRX) recently announced that the company has increased its offer price to acquire Obagi Medical Products, Inc. (OMPI). As per the new agreement, Valeant increased its...

April 04 2013
Zacks
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
APLMApollomics Inc
$ 0.197
(105.42%)
89.32M
SINTSiNtx Technologies Inc
$ 3.30
(61.76%)
3.74M
MNDRMobile health Network Solutions
$ 0.3979
(53.04%)
13.35M
HONEHarborOne Bancorp Inc
$ 19.00
(44.93%)
156
CNOBConnectOne Bancorp Inc
$ 37.01
(36.62%)
123
HURCHurco Companies Inc
$ 12.01
(-44.01%)
2
LYTSLSI Industries Inc
$ 12.01
(-40.16%)
52
JOUTJohnson Outdoors Inc
$ 22.01
(-33.16%)
1
FMAOFarmers and Merchants Bancorp Inc
$ 22.07
(-31.61%)
5
CMAXCareMax Inc
$ 1.15
(-31.55%)
17.39k
APLMApollomics Inc
$ 0.1984
(106.88%)
89.32M
ELABElevai Labs Inc
$ 0.0225
(1.81%)
16.13M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 21.51
(14.97%)
14.25M
MNDRMobile health Network Solutions
$ 0.3979
(53.04%)
13.35M
TSLATesla Inc
$ 345.15
(7.62%)
4.61M

OMPI Discussion

View Posts
BooDog BooDog 12 years ago
Far out. Gives my little guys some hope
congrats!!
👍️0
ospreyeye ospreyeye 12 years ago
OMPI Chart.......Gapper.......huge move today...............$$$

👍️0
Edgenation Edgenation 12 years ago
Ok just sold because of revenue/inventory numbers. I'll be back someday!
👍️0
Edgenation Edgenation 12 years ago
Haha no, just saying that would be nice! but intermediate to long term there is a good chance. We shall see!
👍️0
mlkrborn mlkrborn 12 years ago
In a week?
GL
mlkr
👍️0
Edgenation Edgenation 12 years ago
Just got in today at $14.53. Pretty dead board but the company has great near term potential with a possible buyout still! hopefully this runs to $20 in a week!
👍️0
mlkrborn mlkrborn 13 years ago
Obagi Medical: Addresses response by Obagi Board of Directors to its letter says 'Voce commends Obagi's appointment of strategic advisors, and further welcomes its public commitment that any acquisition offers' (OMPI) 11.87 : The letter stated "On February 10, 2012, Voce sent a letter to the Obagi Board of Directors criticizing the Board's recent adoption of a poison pill and demanding immediate action to address corporate governance deficiencies and to evaluate strategic alternatives. Voce's letter stated that it believed Obagi has spurned recent overtures to acquire the Company. On February 14, 2012, the Obagi Board responded to Voce's letter. The Board's statement notably did not dispute Voce's claims that the Company had recently received and summarily rebuffed offers to acquire Obagi. In addition, the Obagi Board's response states in part: Voce commends Obagi's appointment of strategic advisors, and further welcomes its public commitment that any acquisition offers from this point forward will be reviewed by these independent advisors. Voce believes that this change in Obagi's posture may invite additional acquisition interest....There is substantial strategic interest in an acquisition of Obagi and broad support for a sale of the Company in both the investment and the analyst community. It behooves the Obagi Board to pursue this potential outcome diligently."
👍️0
mlkrborn mlkrborn 15 years ago
Too bad no one covered but up since its creation: Chart!
http://stockcharts.com/h-sc/ui?s=ompi&p=D&yr=0&mn=6&dy=0&id=p97690170109
👍️0
kmx_swing kmx_swing 16 years ago
OMPI board created
👍️0

Your Recent History

NASDAQ
OMPI
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved